PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings
Product Categories
PharmaLegacy Laboratories is a leading speciality pharmacology Contract Research Organization located in Shanghai Zhangjiang High-Tech Park, China. PharmaLegacy is equipped with a world-class facility, working to international pharmaceutical industrial standards. PharmaLegacy provides preclinical in vivo pharmacology efficacy services as well a therapeutic antibody discovery service program. Our state-of-the-art platforms include:· Pioneering work using CD34+ humanized mice that carry a human immune system, to test biologics for immuno-oncology therapeutic efficacy· An NHP platform for therapeutic biologics testing in a variety of immune diseases · An advanced antibody discovery platform based on single B cell antibody sequencing · An internationally recognized Bone/Orthopaedics platform to test both hard tissue disease therapeutic candidates and medical devicesPharmaLegacy offers a full range of preclinical pharmacology services for evaluating pharmacological effects of drug candidates in the areas of inflammation/auto-Immune diseases, lung injury, liver/metabolic diseases and oncology. Our NHP platform and CD34+ humanized mice models have helped dozens of clients with IND filings